Evidence map›Paper›PMID 38374237›Full record

ArticleScientific reports2024

Combined substituent number utilized machine learning for the development of antimicrobial agent.

Keitaro Yamauchi, Hirotaka Nakatsuji, Takaaki Kamishima, Yoshitaka Koseki, Masaki Kubo, Hitoshi Kasai

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Keitaro YamauchiInstitute of Multidisciplinary Research for Advance Materials (IMRAM), Tohoku University, Aoba-Ku, Sendai, Miyagi, 980-8577, Japan.
Hirotaka NakatsujiInstitute of Multidisciplinary Research for Advance Materials (IMRAM), Tohoku University, Aoba-Ku, Sendai, Miyagi, 980-8577, Japan. hirotaka.nakatsuji.d1@tohoku.ac.jp.
Takaaki KamishimaEast Tokyo Laboratory, Genesis Research Institute, Inc., 717-86 Futamata, Ichikawa, Chiba, 272-0001, Japan.
Yoshitaka KosekiInstitute of Multidisciplinary Research for Advance Materials (IMRAM), Tohoku University, Aoba-Ku, Sendai, Miyagi, 980-8577, Japan.
Masaki KuboDepartment of Chemical Engineering, Graduate School of Engineering, Tohoku University, Aoba-Ku, Sendai, Miyagi, 980-8579, Japan.
Hitoshi KasaiInstitute of Multidisciplinary Research for Advance Materials (IMRAM), Tohoku University, Aoba-Ku, Sendai, Miyagi, 980-8577, Japan. kasai@tohoku.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The utilization of machine learning has a potential to improve the environment of the development of antimicrobial agents. For practical use of machine learning, it is important that the conversion of molecules information to an appropriate descriptor because too informative descriptor requires enormous computation time and experiments for gathering data, whereas a less informative descriptor has problems in validity. In this study, we utilized a descriptor only focused on substituent. The type and the position of substituents on the molecules that have a 4-quinolone structure (11,879 compounds) were converted to the combined substituent number (CSN). While the CSN does not include information on the detailed structure, physical properties, and quantum chemistry of molecules, the prediction model constructed by machine learning of CSN indicated a sufficient coefficient of determination (0.719 for the training dataset and 0.519 for the validation dataset). In addition, this CSN can easily construct the unknown molecules library which has a relatively consistent structure by recombination of substituents (32,079,318 compounds) and screening of them. The validity of the prediction model was also confirmed by growth inhibition experiments for E. coli using the model-suggested molecules and commercially available antimicrobial agents.

Indexed as

Escherichia coliMachine Learning

Identifiers

PMID38374237
PMCPMC10876936

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.